The clinical trial produced results that de-risk the development of Kanvas Bio’s lead immuno-oncology drug. PRINCETON, N.J., November 08, 2024--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack ...
As Federation Bio fades away, Kanvas Biosciences has snapped up two of the biotech’s assets as well as its microbial library and the company’s chief scientific officer Lee Swem, Ph.D., to lead program ...
Kanvas Biosciences aims to create a “Google Maps” for the microbiome that can help fine-tune treatments for cancer and other diseases. Over the past two decades, immunotherapies have become a key tool ...
PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, the leader in microbiome mapping technology, today announced it acquired two active therapeutics programs, a microbial library, and intellectual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback